IL1B and neoplasm: This indicates that whilst TNFα and IL-1 signaling were significantly enriched in 5-FU chemo-immunotherapy treated tumors, the robust anti-tumor response produced by this additive chemo-immunotherapy is likely to be dependent on the combination of multiple molecular pathways.